In the Brief Report titled “Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia,”1 published online March 6, 2019, there was a conflict of interest disclosure that had been reported by Dr Tosti prior to publication but was inadvertently omitted from the published article. Dr Tosti reported serving as a consultant to Andrews & Thornton representing plaintiffs in the taxotere litigation. This article was corrected online.
References
- 1.Freites-Martinez A, Chan D, Sibaud V, et al. Assessment of quality of life and treatment outcomes of patients with persistent postchemotherapy alopecia [published online March 6, 2019]. JAMA Dermatol. doi: 10.1001/jamadermatol.2018.5071 [DOI] [PMC free article] [PubMed] [Google Scholar]